Trial intelligence / Profile preview

Calcifediol Dosing Regimens in Elderly Hip Fracture Patients

NCT03213886Phase 4Completed

Start
Jan 2018
Primary completion
Apr 2019
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised trial of calcifediol in Vitamin D deficiency (VDD) (2 arms). Primary endpoint: Functional gain assessed by Barthel Index at 6 months. Started Jan 2018; status: completed.

02

Drugs

calcifediol
03

Conditions

Vitamin D deficiency (VDD)

Beyond the preview

Go deeper on NCT03213886.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03213886.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call